“Adults with congenital heart defects”: current challenges in medical care. Part I: the problem, structure of care, heart failure, cardiac arrhythmias
Tóm tắt
Từ khóa
Tài liệu tham khảo
Osterspey A (2006) Erstellung von Leitlinien in der Deutschen Gesellschaft für Kardiologie – Herz- und Kreislaufforschung e. V. Clin Res Cardiol 95(12):692–695
Kaemmerer H, Freilinger S, Neidenbach R, Achenbach S, Andonian C, Ewert P et al (2022) Versorgung von Erwachsenen mit angeborenen Herzfehlern in Deutschland – tragende Rolle von Internisten und Hausärzten. Internist 63(1):95–102
Kaemmerer H, Andonian C, Ewert P, Freilinger S, Nagdyman N, Neidenbach R et al (2021) Managing transition—Medical follow-up care for adults with congenital heart defects. Dtsch Med Wochenschr 146(18):1192–1199
Andonian C, Beckmann J, Biber S, Ewert P, Freilinger S, Kaemmerer H et al (2018) Current research status on the psychological situation of adults with congenital heart disease. Cardiovasc Diagn Ther 8(6):799–804
Andonian C, Beckmann J, Ewert P, Freilinger S, Kaemmerer H, Oberhoffer-Fritz R et al (2020) Assessment of the psychological situation in adults with congenital heart disease. J Clin Med 9(3):779
Andonian CS, Freilinger S, Achenbach S, Ewert P, Gundlach U, Hoerer J et al (2021) ‘Well-being paradox’ revisited: a cross-sectional study of quality of life in over 4000 adults with congenital heart disease. BMJ Open 11(6):e49531
Neidenbach R et al (2021) Systematic assessment of health care perception in adults with congenital heart disease in Germany. CDT J 481–491. https://doi.org/10.21037/cdt-20-825
Deutsche Herzstiftung e. V. (2020) Deutscher Herzbericht 2019
Seidel L, Nebel K, Achenbach S, Bauer U, Ewert P, Freilinger S et al (2020) Facts about the general medical care of adults with congenital heart defects: experience of a tertiary care center. J Clin Med 9(6):1943
Deutsche Herzstiftung e. V. (2021) Leben mit angeborenen Herzfehlern im Erwachsenenalter – Ein Leitfaden
Diller GP, Orwat S, Lammers AE, Radke RM, De-Torres-Alba F, Schmidt R et al (2021) Lack of specialist care is associated with increased morbidity and mortality in adult congenital heart disease: a population-based study. Eur Heart J 42(41):4241–4248
Mackie AS, Ionescu-Ittu R, Therrien J, Pilote L, Abrahamowicz M, Marelli AJ (2009) Children and adults with congenital heart disease lost to follow-up: who and when? Circulation 120(4):302–309
Gurvitz M, Valente AM, Broberg C, Cook S, Stout K, Kay J et al (2013) Prevalence and predictors of gaps in care among adult congenital heart disease patients: HEART-ACHD (The Health, Education, and Access Research Trial). J Am Coll Cardiol 61(21):2180–2184
Wray J, Frigiola A, Bull C (2013) Loss to specialist follow-up in congenital heart disease; out of sight, out of mind. Heart 99(7):485–490
Marelli AJ, Ionescu-Ittu R, Mackie AS, Guo L, Dendukuri N, Kaouache M (2014) Lifetime prevalence of congenital heart disease in the general population from 2000 to 2010. Circulation 130(9):749–756
van der Linde D, Konings EE, Slager MA, Witsenburg M, Helbing WA, Takkenberg JJ et al (2011) Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis. J Am Coll Cardiol 58(21):2241–2247
Verheugt CL, Uiterwaal CS, van der Velde ET, Meijboom FJ, Pieper PG, van Dijk AP et al (2010) Mortality in adult congenital heart disease. Eur Heart J 31(10):1220–1229
Zomer AC, Vaartjes I, van der Velde ET, de Jong HM, Konings TC, Wagenaar LJ et al (2013) Heart failure admissions in adults with congenital heart disease; risk factors and prognosis. Int J Cardiol 168(3):2487–2493
Brida M, Lovric D, Griselli M, Riesgo Gil F, Gatzoulis MA (2022) Heart failure in adults with congenital heart disease. Int J Cardiol 357:39–45
Menachem JN, Schlendorf KH, Mazurek JA, Bichell DP, Brinkley DM, Frischhertz BP et al (2020) Advanced heart failure in adults with congenital heart disease. JACC Heart Fail 8(2):87–99
Brida M, Diller GP, Gatzoulis MA (2018) Systemic right ventricle in adults with congenital heart disease: anatomic and phenotypic spectrum and current approach to management. Circulation 137(5):508–518
Baumgartner H, De Backer J, Babu-Narayan SV, Budts W, Chessa M, Diller GP et al (2021) 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 42(6):563–645
Budts W, Roos-Hesselink J, Radle-Hurst T, Eicken A, McDonagh TA, Lambrinou E et al (2016) Treatment of heart failure in adult congenital heart disease: a position paper of the Working Group of Grown-Up Congenital Heart Disease and the Heart Failure Association of the European Society of Cardiology. Eur Heart J 37(18):1419–1427
Leczycki P, Banach M, Maciejewski M, Bielecka-Dabrowa A (2022) Heart failure risk predictions and prognostic factors in adults with congenital heart diseases. Front Cardiovasc Med 9:692815
McDonagh TA, Metra M, Adamo M, Gardner RS, Baumbach A, Bohm M et al (2021) 2021 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur Heart J 42(36):3599–3726
Dodd K, Lampert BC (2018) The use and indication of Ivabradine in heart failure. Heart Fail Clin 14(4):493–500
Zengin E, Sinning C, Blaum C, Blankenberg S, Rickers C, von Kodolitsch Y et al (2021) Heart failure in adults with congenital heart disease: a narrative review. Cardiovasc Diagn Ther 11(2):529–537
Ephrem G, McCollum JC, Green-Hess D, Guglin ME, Sawada SG, Rao RA (2022) Subjective and objective impact of Angiotensin receptor-neprilysin inhibitors on systemic right ventricle patients. Heart Lung Circ 31(7):964–973
Maurer SJ, Pujol Salvador C, Schiele S, Hager A, Ewert P, Tutarel O (2020) Sacubitril/valsartan for heart failure in adults with complex congenital heart disease. Int J Cardiol 300:137–140
Packer M, Butler J, Zannad F, Filippatos G, Ferreira JP, Pocock SJ et al (2021) Effect of Empagliflozin on worsening heart failure events in patients with heart failure and preserved ejection fraction: EMPEROR-preserved trial. Circulation 144(16):1284–1294
Armstrong PW, Pieske B, Anstrom KJ, Ezekowitz J, Hernandez AF, Butler J et al (2020) Vericiguat in patients with heart failure and reduced ejection fraction. N Engl J Med 382(20):1883–1893
Gunderson EG, Lillyblad MP, Fine M, Vardeny O, Berei TJ (2019) Tolvaptan for volume management in heart failure. Pharmacotherapy 39(4):473–485
Hernandez-Madrid A, Paul T, Abrams D, Aziz PF, Blom NA, Chen J et al (2018) Arrhythmias in congenital heart disease: a position paper of the European Heart Rhythm Association (EHRA), Association for European Paediatric and Congenital Cardiology (AEPC), and the European Society of Cardiology (ESC) Working Group on Grown-up Congenital heart disease, endorsed by HRS, PACES, APHRS, and SOLAECE. Europace 20(11):1719–1753
Boucek D, Yetman AT, Yeung E, Miyamoto SD, Stehlik J, Kfoury AG et al (2014) Survival based on patient selection for heart transplant in adults with congenital heart disease: a multi-institutional study. Int J Cardiol 172(1):e89–90
Everitt MD, Donaldson AE, Stehlik J, Kaza AK, Budge D, Alharethi R et al (2011) Would access to device therapies improve transplant outcomes for adults with congenital heart disease? Analysis of the United Network for Organ Sharing (UNOS). J Heart Lung Transplant 30(4):395–401
Bouchardy J, Therrien J, Pilote L, Ionescu-Ittu R, Martucci G, Bottega N et al (2009) Atrial arrhythmias in adults with congenital heart disease. Circulation 120(17):1679–1686
Khairy P, Harris L, Landzberg MJ, Fernandes SM, Barlow A, Mercier LA et al (2008) Sudden death and defibrillators in transposition of the great arteries with intra-atrial baffles: a multicenter study. Circ Arrhythm Electrophysiol 1(4):250–257
Wasmer K, Eckardt L, Baumgartner H, Kobe J (2021) Therapy of supraventricular and ventricular arrhythmias in adults with congenital heart disease-narrative review. Cardiovasc Diagn Ther 11(2):550–562
Labombarda F, Hamilton R, Shohoudi A, Aboulhosn J, Broberg CS, Chaix MA et al (2017) Increasing prevalence of atrial fibrillation and permanent atrial arrhythmias in congenital heart disease. J Am Coll Cardiol 70(7):857–865
Wasmer K, Kobe J, Dechering DG, Bittner A, Monnig G, Milberg P et al (2013) Isthmus-dependent right atrial flutter as the leading cause of atrial tachycardias after surgical atrial septal defect repair. Int J Cardiol 168(3):2447–2452
Waldmann V, Khairy P (2021) Pathophysiology, risk factors, and management of atrial fibrillation in adult congenital heart disease. Card Electrophysiol Clin 13(1):191–199
de Groot NM, Zeppenfeld K, Wijffels MC, Chan WK, Blom NA, Van der Wall EE et al (2006) Ablation of focal atrial arrhythmia in patients with congenital heart defects after surgery: role of circumscribed areas with heterogeneous conduction. Heart Rhythm 3(5):526–535
Iturralde P, Nava S, Salica G, Medeiros A, Marquez MF, Colin L et al (2006) Electrocardiographic characteristics of patients with Ebstein’s anomaly before and after ablation of an accessory atrioventricular pathway. J Cardiovasc Electrophysiol 17(12):1332–1336
Kapel GF, Sacher F, Dekkers OM, Watanabe M, Blom NA, Thambo JB et al (2017) Arrhythmogenic anatomical isthmuses identified by electroanatomical mapping are the substrate for ventricular tachycardia in repaired Tetralogy of Fallot. Eur Heart J 38(4):268–276
Kobe J, Willy K, Eckardt L, Baumgartner H, Wasmer K (2021) Narrative review of: risk stratification and implantable cardioverter-defibrillator therapy in adults with congenital heart disease. Cardiovasc Diagn Ther 11(2):538–549
Khairy P, Van Hare GF, Balaji S, Berul CI, Cecchin F, Cohen MI et al (2014) PACES/HRS Expert consensus statement on the recognition and management of arrhythmias in adult congenital heart disease: developed in partnership between the Pediatric and Congenital Electrophysiology Society (PACES) and the Heart Rhythm Society (HRS). Endorsed by the governing bodies of PACES, HRS, the American College of Cardiology (ACC), the American Heart Association (AHA), the European Heart Rhythm Association (EHRA), the Canadian Heart Rhythm Society (CHRS), and the International Society for Adult Congenital Heart Disease (ISACHD). Heart Rhythm 11(10):e102–65
Baruteau AE, Pass RH, Thambo JB, Behaghel A, Le Pennec S, Perdreau E et al (2016) Congenital and childhood atrioventricular blocks: pathophysiology and contemporary management. Eur J Pediatr 175(9):1235–1248
Huhta JC, Maloney JD, Ritter DG, Ilstrup DM, Feldt RH (1983) Complete atrioventricular block in patients with atrioventricular discordance. Circulation 67(6):1374–1377
Liberman L, Silver ES, Chai PJ, Anderson BR (2016) Incidence and characteristics of heart block after heart surgery in pediatric patients: A multicenter study. J Thorac Cardiovasc Surg 152(1):197–202
Lin A, Mahle WT, Frias PA, Fischbach PS, Kogon BE, Kanter KR et al (2010) Early and delayed atrioventricular conduction block after routine surgery for congenital heart disease. J Thorac Cardiovasc Surg 140(1):158–160
Batra AS, Wells WJ, Hinoki KW, Stanton RA, Silka MJ (2003) Late recovery of atrioventricular conduction after pacemaker implantation for complete heart block associated with surgery for congenital heart disease. J Thorac Cardiovasc Surg 125(6):1291–1293
Squarcia U, Merideth J, McGoon DC, Weidman WH (1971) Prognosis of transient atrioventricular conduction disturbances complicating open heart surgery for congenital heart defects. Am J Cardiol 28(6):648–652
Ghonim S, Gatzoulis MA, Ernst S, Li W, Moon JC, Smith GC et al (2022) Predicting survival in repaired tetralogy of Fallot: a lesion-specific and personalized approach. JACC Cardiovasc Imaging 15(2):257–268
Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstrom-Lundqvist C et al (2021) 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the European Society of Cardiology (ESC) Developed with the special contribution of the European Heart Rhythm Association (EHRA) of the ESC. Eur Heart J 42(5):373–498
Yang H, Bouma BJ, Dimopoulos K, Khairy P, Ladouceur M, Niwa K et al (2020) Non-vitamin K antagonist oral anticoagulants (NOACs) for thromboembolic prevention, are they safe in congenital heart disease? Results of a worldwide study. Int J Cardiol 299:123–130
Freisinger E, Gerss J, Makowski L, Marschall U, Reinecke H, Baumgartner H et al (2020) Current use and safety of novel oral anticoagulants in adults with congenital heart disease: results of a nationwide analysis including more than 44 000 patients. Eur Heart J 41(43):4168–4177
Koyak Z, Kroon B, de Groot JR, Wagenaar LJ, van Dijk AP, Mulder BA et al (2013) Efficacy of antiarrhythmic drugs in adults with congenital heart disease and supraventricular tachycardias. Am J Cardiol 112(9):1461–1467
Fish FA, Gillette PC, Benson DW Jr. (1991) Proarrhythmia, cardiac arrest and death in young patients receiving encainide and flecainide. The Pediatric Electrophysiology Group. J Am Coll Cardiol 18(2):356–365
Konemann H, Frommeyer G, Zeppenfeld K, Eckardt L (2023) The new ESC guidelines on the management of ventricular tachyarrhythmias: Implications for daily practice. Herz 48(1):3–14
van Zyl M, Kapa S, Padmanabhan D, Chen FC, Mulpuru SK, Packer DL et al (2016) Mechanism and outcomes of catheter ablation for ventricular tachycardia in adults with repaired congenital heart disease. Heart Rhythm 13(7):1449–1454
Moore JP, Seki A, Shannon KM, Mandapati R, Tung R, Fishbein MC (2013) Characterization of anatomic ventricular tachycardia isthmus pathology after surgical repair of tetralogy of Fallot. Circ Arrhythm Electrophysiol 6(5):905–911
Zeppenfeld K, Tfelt-Hansen J, de Riva M, Winkel BG, Behr ER, Blom NA et al (2022) 2022 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death. Eur Heart J 43(40):3997–4126
Bertels RA, Harteveld LM, Filippini LH, Clur SA, Blom NA (2017) Left ventricular dysfunction is associated with frequent premature ventricular complexes and asymptomatic ventricular tachycardia in children. Europace 19(4):617–621
Janousek J, van Geldorp IE, Krupickova S, Rosenthal E, Nugent K, Tomaske M et al (2013) Permanent cardiac pacing in children: choosing the optimal pacing site: a multicenter study. Circulation 127(5):613–623
Glikson M, Nielsen JC, Kronborg MB, Michowitz Y, Auricchio A, Barbash IM et al (2021) 2021 ESC Guidelines on cardiac pacing and cardiac resynchronization therapy. Eur Heart J 42(35):3427–3520
Opic P, Yap SC, Van Kranenburg M, Van Dijk AP, Budts W, Vliegen HW et al (2013) Atrial-based pacing has no benefit over ventricular pacing in preventing atrial arrhythmias in adults with congenital heart disease. Europace 15(12):1757–1762
Krongrad E (1978) Prognosis for patients with congenital heart disease and postoperative intraventricular conduction defects. Circulation 57(5):867–870
Koyak Z, Harris L, de Groot JR, Silversides CK, Oechslin EN, Bouma BJ et al (2012) Sudden cardiac death in adult congenital heart disease. Circulation 126(16):1944–1954
Kella DK, Merchant FM, Veledar E, Book W, Lloyd MS (2014) Lesion-specific differences for implantable cardioverter defibrillator therapies in adults with congenital heart disease. Pacing Clin Electrophysiol 37(11):1492–1498
Santharam S, Hudsmith L, Thorne S, Clift P, Marshall H, De Bono J (2017) Long-term follow-up of implantable cardioverter-defibrillators in adult congenital heart disease patients: indications and outcomes. Europace 19(3):407–413
Frommeyer G, Feder S, Bettin M, Debus V, Kobe J, Reinke F et al (2018) Long-term single-center experience of defibrillator therapy in children and adolescents. Int J Cardiol 271:105–108
Vehmeijer JT, Brouwer TF, Limpens J, Knops RE, Bouma BJ, Mulder BJ et al (2016) Implantable cardioverter-defibrillators in adults with congenital heart disease: a systematic review and meta-analysis. Eur Heart J 37(18):1439–1448